The nominal value of the own shares acquired by this method shall not exceed 10% of the company’s subscribed share capital, it said.
It said a maximum number of 1.77 million own shares will be offered to former or existing management members or to former or existing employees of some of the company’s subsidiaries.
Medlife shareholders also authorized the board of directors to negotiate with BCR and other lenders the terms and conditions to raise a syndicated credit line contracted in September 2019 to EUR110 million.
Medlife also seeks to negotiate the extension of the reimbursement of the existing facilities’ period, the rearrangement of subsequent terms and conditions and the amendment of guarantees under the loan facility.